Toll-like receptor-4 is a mediator of proliferation in esophageal adenocarcinoma
Ingredients: Coconut Oil, water, Sodium Hydroxide, Salicylic Acid, Fragrance, Glucono-delta Lactone, Sodium Lactate, Butylated Hydroxytoluene, Citrus Medica, Limonium Peel Powder, Lactic Acid, Tranexamic Acid, D&C Orange 4 (Cl15510), Tetrasodium EDTA, Tocopheryl Acetate, Kojic Acid
Overall, sulforaphanes safety profile appears favorable, with manageable adverse events supporting its use as a treatment adjunct, pending further long-term safety data
That means non-injectable GHK-Cu is being evaluated under the 503A interim policy, while injectable-route GHK-Cu should not be described as broadly reopened, FDA-approved, or available through the same pathway